AMAG Pharma Appoints CFO

Edward (Ted) Myles has been appointed senior vice president, chief financial officer and treasurer of AMAG. Mr. Myles will be responsible for AMAG’s financial and capital markets activities and will oversee the accounting, tax, corporate finance and investor relations teams. Mr. Myles reports to Frank Thomas, president and chief operating officer of AMAG.
 
“We are pleased to have Ted join us as CFO,” said Mr. Thomas. “Ted is an accomplished executive with a proven track record of financial and operational leadership in the biopharmaceutical industry. His experience in corporate finance, coupled with various roles in accounting and investment banking earlier in his career, make Ted an important addition to the executive leadership team. He will play a critical role in our continued efforts to fund the growth of the company and to create additional shareholder value.”
 
Mr. Myles has more than 20 years of public and private corporate finance and operational experience in the biotechnology, pharmaceutical and medical device industries. Prior to joining the company, he held various positions at Ocata Therapeutics, Inc., most recently as chief financial officer and chief operating officer. Mr. Myles also served as chief financial officer and vice president of operations at PrimeraDx, Inc., senior vice president of finance and chief financial officer of Pressure Biosciences, Inc., and controller at EMD Pharmaceuticals, Inc.